Hydroxyethyl starch and fluid resuscitation. Patient-oriented outcome is the “right way”
01 Pubblicazione su rivista
Giordano G., Pugliese F., Bilotta F.
ISSN: 0883-9441
he intensive care unit (ICU) [1].
Fluid resuscitation is a relevant topic in critical care and the debate on optimal fluid management is evolving. Hydroxyethyl starch (HES)
is a colloid used for volume replacement therapy with a controversial history: recently HES-derived products' market authorizations have
been reevaluated and more restrictive rules have been released [2-5].
In the United States, the Food and Drug Administration has been requested to withdraw HES-based products by Public Citizen, a nonprofit
consumer advocacy organization [2,3].
I